BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19916193)

  • 1. [Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication].
    Borg R; Nerup J; Nathan DM; Kuenen J; Zheng H; Schoenfeld D; Heine RJ;
    Ugeskr Laeger; 2009 Nov; 171(45):3262-5. PubMed ID: 19916193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between glycated haemoglobin levels and mean glucose levels over time.
    Nathan DM; Turgeon H; Regan S
    Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.
    Kovatchev BP; Cox DJ; Kumar A; Gonder-Frederick L; Clarke WL
    Diabetes Technol Ther; 2003; 5(5):817-28. PubMed ID: 14633347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
    Pupillo M; De Berardis G; Antenucci D; Minnucci A; Nicolucci A
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e1-3. PubMed ID: 18258329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study.
    Chubb SA; Van Minnen K; Davis WA; Bruce DG; Davis TM
    Diabetes Res Clin Pract; 2011 Dec; 94(3):371-6. PubMed ID: 21862165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring and haemoglobin A(1c).
    Sharp P; Rainbow S
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):516-7. PubMed ID: 12227860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical estimation of HbA(1c) from routine self-monitoring data in people with type 1 and type 2 diabetes mellitus.
    Kovatchev BP; Cox DJ
    Methods Enzymol; 2004; 384():94-106. PubMed ID: 15081683
    [No Abstract]   [Full Text] [Related]  

  • 12. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating the A1C assay into estimated average glucose values.
    Nathan DM; Kuenen J; Borg R; Zheng H; Schoenfeld D; Heine RJ;
    Diabetes Care; 2008 Aug; 31(8):1473-8. PubMed ID: 18540046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.
    Bonora E; Calcaterra F; Lombardi S; Bonfante N; Formentini G; Bonadonna RC; Muggeo M
    Diabetes Care; 2001 Dec; 24(12):2023-9. PubMed ID: 11723077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
    Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
    Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
    Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
    Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
    Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
    Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Propositions for the standardized expression of HbA 1c results].
    Gillery P; Périer C; Bordas-Fonfrède M; Hue G; Chapelle JP; Vexiau P; Vialettes B
    Ann Biol Clin (Paris); 2009; 67(6):669-71. PubMed ID: 19939770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.